secwatch.observer — SEC 8-K summary ====================================== Issuer: CDT Equity Inc. (CDT) CIK: 0001896212 Form: 8-K Filed at: 2023-09-29T23:59:59+00:00 Accession: 0001493152-23-034700 Event type: m_and_a Sentiment: neutral Materiality: 0.90 Item codes: 1.01, 5.02, 2.01, 5.06, 9.01, 3.02, 3.01, 3.03, 5.03, 5.01, 5.05, 7.01 LLM model: deepseek-v4-flash:cloud@v2 Murphy Canyon completes de-SPAC merger with Conduit Pharmaceuticals Ltd. ------------------------------------------------------------------------ - Transaction closed Sept 22, 2023; name changed to Conduit Pharmaceuticals Inc.; tickers CDT, CDTTW. - Post-combination shares outstanding: 72,418,316; 2,129,662 public shares redeemed at ~$10.84. - $20M PIPE financing from Nirland Limited: 2M units at $10/unit (1 share + 1 warrant). - Andrew Regan beneficially owns 62.9% (45.6M shares) of outstanding common stock. - Lock-up agreements for 180 days for certain former Conduit shareholders. Source: EDGAR index: https://www.sec.gov/Archives/edgar/data/1896212/000149315223034700/0001493152-23-034700-index.htm Primary doc: https://www.sec.gov/Archives/edgar/data/1896212/000149315223034700/form8-k.htm HTML page: https://secwatch.observer/filing/0001493152-23-034700 License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer